IBDEI0EA ; ; 06-AUG-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,6508,1,5,0)
 ;;=5^Urogenital Candidiasis
 ;;^UTILITY(U,$J,358.3,6508,2)
 ;;=^266866
 ;;^UTILITY(U,$J,358.3,6509,0)
 ;;=600.01^^31^411^5
 ;;^UTILITY(U,$J,358.3,6509,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6509,1,4,0)
 ;;=4^600.01
 ;;^UTILITY(U,$J,358.3,6509,1,5,0)
 ;;=5^BPH with Obstruction
 ;;^UTILITY(U,$J,358.3,6509,2)
 ;;=^329933
 ;;^UTILITY(U,$J,358.3,6510,0)
 ;;=600.10^^31^411^39
 ;;^UTILITY(U,$J,358.3,6510,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6510,1,4,0)
 ;;=4^600.10
 ;;^UTILITY(U,$J,358.3,6510,1,5,0)
 ;;=5^Nod Prostate W/O UR Obst
 ;;^UTILITY(U,$J,358.3,6510,2)
 ;;=^329934
 ;;^UTILITY(U,$J,358.3,6511,0)
 ;;=585.9^^31^411^8
 ;;^UTILITY(U,$J,358.3,6511,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6511,1,4,0)
 ;;=4^585.9
 ;;^UTILITY(U,$J,358.3,6511,1,5,0)
 ;;=5^Chronic Renal Failure
 ;;^UTILITY(U,$J,358.3,6511,2)
 ;;=^332812
 ;;^UTILITY(U,$J,358.3,6512,0)
 ;;=788.64^^31^411^61
 ;;^UTILITY(U,$J,358.3,6512,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6512,1,4,0)
 ;;=4^788.64
 ;;^UTILITY(U,$J,358.3,6512,1,5,0)
 ;;=5^Urinary Hesitancy
 ;;^UTILITY(U,$J,358.3,6512,2)
 ;;=^334165
 ;;^UTILITY(U,$J,358.3,6513,0)
 ;;=788.65^^31^411^52
 ;;^UTILITY(U,$J,358.3,6513,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6513,1,4,0)
 ;;=4^788.65
 ;;^UTILITY(U,$J,358.3,6513,1,5,0)
 ;;=5^Straining of Urination
 ;;^UTILITY(U,$J,358.3,6513,2)
 ;;=^334166
 ;;^UTILITY(U,$J,358.3,6514,0)
 ;;=600.00^^31^411^4
 ;;^UTILITY(U,$J,358.3,6514,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6514,1,4,0)
 ;;=4^600.00
 ;;^UTILITY(U,$J,358.3,6514,1,5,0)
 ;;=5^BPH w/o Obstruction
 ;;^UTILITY(U,$J,358.3,6514,2)
 ;;=^334276
 ;;^UTILITY(U,$J,358.3,6515,0)
 ;;=599.70^^31^411^17
 ;;^UTILITY(U,$J,358.3,6515,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6515,1,4,0)
 ;;=4^599.70
 ;;^UTILITY(U,$J,358.3,6515,1,5,0)
 ;;=5^Hematuria
 ;;^UTILITY(U,$J,358.3,6515,2)
 ;;=^336751
 ;;^UTILITY(U,$J,358.3,6516,0)
 ;;=599.71^^31^411^18
 ;;^UTILITY(U,$J,358.3,6516,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6516,1,4,0)
 ;;=4^599.71
 ;;^UTILITY(U,$J,358.3,6516,1,5,0)
 ;;=5^Hematuria, Gross
 ;;^UTILITY(U,$J,358.3,6516,2)
 ;;=^336611
 ;;^UTILITY(U,$J,358.3,6517,0)
 ;;=599.72^^31^411^19
 ;;^UTILITY(U,$J,358.3,6517,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6517,1,4,0)
 ;;=4^599.72
 ;;^UTILITY(U,$J,358.3,6517,1,5,0)
 ;;=5^Hematuria, Microscopic
 ;;^UTILITY(U,$J,358.3,6517,2)
 ;;=^336612
 ;;^UTILITY(U,$J,358.3,6518,0)
 ;;=596.89^^31^411^12
 ;;^UTILITY(U,$J,358.3,6518,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6518,1,4,0)
 ;;=4^596.89
 ;;^UTILITY(U,$J,358.3,6518,1,5,0)
 ;;=5^Cystocele
 ;;^UTILITY(U,$J,358.3,6518,2)
 ;;=^87989
 ;;^UTILITY(U,$J,358.3,6519,0)
 ;;=185.^^31^411^35
 ;;^UTILITY(U,$J,358.3,6519,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6519,1,4,0)
 ;;=4^185.
 ;;^UTILITY(U,$J,358.3,6519,1,5,0)
 ;;=5^Prostate CA
 ;;^UTILITY(U,$J,358.3,6519,2)
 ;;=^99481
 ;;^UTILITY(U,$J,358.3,6520,0)
 ;;=608.9^^31^411^34
 ;;^UTILITY(U,$J,358.3,6520,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6520,1,4,0)
 ;;=4^608.9
 ;;^UTILITY(U,$J,358.3,6520,1,5,0)
 ;;=5^Male Genital Symptoms
 ;;^UTILITY(U,$J,358.3,6520,2)
 ;;=^123856
 ;;^UTILITY(U,$J,358.3,6521,0)
 ;;=608.9^^31^411^53
 ;;^UTILITY(U,$J,358.3,6521,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6521,1,4,0)
 ;;=4^608.9
 ;;^UTILITY(U,$J,358.3,6521,1,5,0)
 ;;=5^Testicular Pain
 ;;^UTILITY(U,$J,358.3,6521,2)
 ;;=^123856
 ;;^UTILITY(U,$J,358.3,6522,0)
 ;;=788.63^^31^411^59
 ;;^UTILITY(U,$J,358.3,6522,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,6522,1,4,0)
 ;;=4^788.63
 ;;^UTILITY(U,$J,358.3,6522,1,5,0)
 ;;=5^Urgency of Urination
 ;;
 ;;$END ROU IBDEI0EA
